Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

62462 1500648800HCLSReviewMexicoJuly2017.pdf
Energy Boardroom

Merck KGaA to pour $138M into biosimilars, licensing instead of M&A

09.05.2014 / Fierce Pharma

Merck KGaA company executives told shareholders at its annual meeting on Friday that future growth may be less about giant acquisitions than it is about making strategic deals and internal changes to boost its pipeline.

LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: